A Comparative Study of Allopathy and Ayurveda Medicines in the Treatment of Type 2 Diabetes Mellitus and its Clinical Impact

被引:0
|
作者
Bindu, Radhika [1 ]
Dharamsi, Abhay [2 ]
机构
[1] Parul Univ, Parul Inst Pharm, Dept Pharm Practice, Fac Pharm, Vadodara, Gujarat, India
[2] Parul Univ, Fac Pharm, Parul Inst Pharm, Dept Pharmaceut, Vadodara, Gujarat, India
关键词
Allopathy; Ayurveda; Clinical Impact; Comparative study; Diabetes Mellitus;
D O I
10.5530/jyp.2023.15.104
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Type 2 Diabetes Mellitus (T2DM) is a complex disorder that has major health and economic consequences. Human beings have been using the herbal and allopathic systems of medicine since a long time to cure, treat, diagnose and prevent various disease and ailments. One such example is T2DM. In Ayurveda, the corresponding term for Diabetes is "Madhumeha" Unlike the ayurvedic system; the allopathic method is more scientifically proven, regulated and developed since decades. Aim: This work comparatively analyzes the Allopathic and Ayurveda treatment in T2DM patients. Materials and Methods: A Prospective Longitudinal Study was conducted in 2 tertiary care teaching hospitals that enrolled 100 patients each in Allopathy and Ayurveda groups. Results: Out of 200 patients, male patients were higher in number. The prevalence was higher in the 50 - 60 years age group which has been a greater risk factor for developing diabetes. We have used the Kuppuswamy Scale for the socio- economic categorization in this study and found Lower Middle-class patients were higher in the Allopathy study group and Upper Lower- class patients were dominant in the Ayurveda study group. Conclusion: Better glycemic control was achieved with the Allopathy group over Ayurveda group (p Value: 0.0468*). Random Blood Sugar levels were reduced in the allopathy group which was statistically significant (p Value: 0.0308*) compared to the Ayurveda group.
引用
收藏
页码:755 / 759
页数:5
相关论文
共 50 条
  • [31] Treatment of type 2 diabetes mellitus
    Feinglos, MN
    Bethel, MA
    MEDICAL CLINICS OF NORTH AMERICA, 1998, 82 (04) : 757 - +
  • [32] Treatment of the Diabetes Mellitus Type 2
    Matthaei, S.
    Bierwirth, R.
    Fritsche, A.
    Gallwitz, B.
    Haering, H.-U.
    Joost, H. -G
    Kellerer, M.
    Kloos, C.
    Kunt, T.
    Nauck, M.
    Schernthaner, G.
    Siegel, E.
    Thienel, F.
    DIABETOLOGIE UND STOFFWECHSEL, 2009, 4 : S138 - S143
  • [33] Treatment of Diabetes mellitus Type 2
    Matthaei, S.
    Bierwirth, R.
    Fritsche, A.
    Gallwitz, B.
    Haering, H. -U.
    Joost, H. -G.
    Kellerer, M.
    Kloos, C.
    Kunt, T.
    Nauck, M.
    Schernthaner, G.
    Siegel, E.
    Thienel, F.
    DIABETOLOGIE UND STOFFWECHSEL, 2010, 5 : S127 - S132
  • [34] Treatment of diabetes mellitus type 2
    Matthaei, S.
    Haering, H. U.
    DIABETOLOGIE UND STOFFWECHSEL, 2008, 3 : S157 - S161
  • [35] A Comparative Study on the Fasting and the Postprandial Dyslipidaemia in Type 2 Diabetes Mellitus
    Suryabhan, Lokhande L.
    Chandrashekhar, Iyer M.
    Ratnendra, Shinde R.
    Prerna, Nandedkar D.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2013, 7 (04) : 627 - 630
  • [36] Pioglitazone in the treatment of type 2 diabetes mellitus: US clinical experience
    Buse, JB
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2000, 108 : S250 - S255
  • [37] Dementia and its associations in type 2 diabetes mellitus: The Fremantle Diabetes Study
    Bruce, DG
    Harrington, N
    Davis, WA
    Davis, TME
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2001, 53 (03) : 165 - 172
  • [38] INSTITUTIONAL CLINICAL PRACTICE IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN MEXICO
    Juarez-Garcia, A.
    Vargas-Valencia, J.
    Martinez-Rivera, G.
    Sotelo-Guzman, M.
    Elias-Lopez, J., I
    Zamora-Barron, M.
    Rangel, S.
    VALUE IN HEALTH, 2011, 14 (07) : A556 - A556
  • [39] Impact of family history of type 2 diabetes mellitus on clinical and metabolic profile in Mexican subjects with type 1 diabetes mellitus
    Escalante-Pulido, M
    Martinez, C
    Milke, E
    Muñoz, T
    Ramos, C
    Mendoza, M
    DIABETES, 2003, 52 : A498 - A498
  • [40] Saxagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus
    Kulasa, Kristen
    Edelman, Steven
    CORE EVIDENCE, 2010, 5 : 23 - 37